ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,491.25
-0.63%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Wave Life Sciences Ltd (WVE)

  7. Wave Life Sciences Ltd (WVE) Noticias

WVE Wave Life Sciences Ltd

6.14
0.26 (4.42%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Wave Life Sciences Ltd WVE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.26 4.42% 6.14 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.93 5.90 6.3799 6.14 5.88
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:30GLOBEWave Life Sciences First Quarter 2024 Financial Results..
30/4/202407:30GLOBEWave Life Sciences Announces Approval of First Clinical..
23/4/202407:30GLOBEWave Life Sciences Announces Continued Momentum in GSK..
27/3/202407:30GLOBEWave Life Sciences to Present at Upcoming Investor..
06/3/202406:55EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202406:39EDGAR2Form 8-K - Current report
06/3/202406:30GLOBEWave Life Sciences Reports Fourth Quarter and Full Year 2023..
28/2/202407:30GLOBEWave Life Sciences Fourth Quarter and Full Year 2023..
27/2/202407:30GLOBEWave Life Sciences Announces Upcoming Presentations at MDA..
12/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:11EDGAR2Form 8-K - Current report
08/1/202407:00GLOBEWave Life Sciences Highlights Recent Achievements and..
04/1/202415:07EDGAR2Form 8-K - Current report
03/1/202407:30GLOBEWave Life Sciences to Present at 42nd Annual J.P. Morgan..
15/12/202307:36EDGAR2Form 8-K - Current report
15/12/202307:30GLOBEWave Life Sciences Announces Initiation of Dosing in Phase 2..
08/12/202305:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/12/202320:26EDGAR2Form 8-K - Current report
07/12/202306:00GLOBEWave Life Sciences Prices $100 Million Public Offering of..
06/12/202315:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202315:10GLOBEWave Life Sciences Announces Proposed Public Offering of..
06/12/202315:08GLOBEWave Life Sciences Announces Initiation of Dosing in..
22/11/202307:30GLOBEWave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI..
09/11/202315:27EDGAR2Form 8-K - Current report
09/11/202307:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202307:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202306:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:39EDGAR2Form 8-K - Current report
09/11/202306:30GLOBEWave Life Sciences Reports Third Quarter 2023 Financial..
03/11/202315:05GLOBEWave Life Sciences Third Quarter 2023 Financial Results..
02/10/202306:31EDGAR2Form 8-K - Current report
28/9/202315:15GLOBEWave Life Sciences Highlights Growth Strategy for Building..
25/9/202307:30GLOBEWave Life Sciences to Present at the Chardan 7th Annual..
06/9/202307:30GLOBEWave Life Sciences to Present at the H.C. Wainwright 25th..
05/9/202315:05EDGAR2Form 8-K - Current report
05/9/202306:30GLOBEWave Life Sciences Announces Submission of First Clinical..
23/8/202320:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:55EDGAR2Form 144 - Report of proposed sale of securities
09/8/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202316:01EDGAR2Form 8-K - Current report
03/8/202306:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202306:37EDGAR2Form 8-K - Current report
03/8/202306:30GLOBEWave Life Sciences Reports Second Quarter 2023 Financial..
27/7/202307:30GLOBEWave Life Sciences Second Quarter 2023 Financial Results..

Su Consulta Reciente

NASDAQ
WVE
Wave Life Sciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados